Andrea Michelle Guggenbickler

Mrs. Andrea Michelle Guggenbickler

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in Social Sciences
Verified
Journal Article
Open access
PDF file
ZGZahra Goliaei
Zahra Goliaei
ZCZaina Chaban
Zaina Chaban
SASeyedeh Ala Amrei
Seyedeh Ala Amrei
YAYasamin Pashmineh Azar
Yasamin Pashmineh Azar
LALaila Z Afzal
Laila Z Afzal
AGAndrea Michelle Guggenbickler
Andrea Michelle Guggenbickler
Intimate Partner Domestic Violence (IPDV) has been reported to be high in minorities across the US. Among minorities, refugees and immigrants encounter particular barriers that may influence their responses to IPDV. This scoping review examined three decades of literature (1980–2022) on resettled married Afghan and Arab refugee women’s attitudes and behaviors toward IPDV in their host countries, aiming to explore gaps in the research, practice, and policy recommendations. Based on the Arksey and O’Malley model, our scoping review conducted extensive searches in SCOPUS, PubMed, PsychInfo, CINAHL, the Web of Science, the Directory of Open Access Journals, and the Embase databases. Searches identified articles that examined resettled Afghan and/or Arab refugees’ responses to IPDV in Western countries. The search identified 439 unique citations; 17 met the inclusion/exclusion criteria. The major findings included acculturative changes in refugee attitudes and behaviors and in stakeholders’ perspectives. Significant attitudinal changes (acknowledgment, silence, justification, or IPDV disapproval) contrasted with less behavioral changes (help-seeking behaviors, or action plans), or changes in barriers to actions, and with a resistance to change in stakeholders (cultural norms and beliefs, the community patriarchal normalization of violence, service providers’ unfamiliarity with client diversity and refugee cultures) in supporting women’s decision-making regarding IPDV. Not a single article made explicit policy recommendations.

30 September 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
AGAndrea Michelle Guggenbickler
Andrea Michelle Guggenbickler
HBHeather K Barr
Heather K Barr
JHJeffrey S Hoch
Jeffrey S Hoch
CDCarolyn S. Dewa
Carolyn S. Dewa
Cost-effectiveness analysis (CE Analysis) provides evidence about the incremental gains in patient outcomes costs from new treatments and interventions in cancer care. The utilization of “real-world” data allows these analyses to better reflect differences in costs and effects for actual patient populations with comorbidities and a range of ages as opposed to randomized controlled trials, which use a restricted population. This rapid review was done through PubMed and Google Scholar in July 2022. Relevant articles were summarized and data extracted to summarize changes in costs (in 2022 CAD) and effectiveness in cancer care once funded by the Canadian government payer system. We conducted statistical analyses to examine the differences between means and medians of costs, effects, and incremental cost effectiveness ratios (ICERs). Twenty-two studies were selected for review. Of those, the majority performed a CE Analysis on cancer drugs. Real-world cancer drug studies had significantly higher costs and effects than non-drug therapies. Studies that utilized a model to project longer time-horizons saw significantly smaller ICER values for the treatments they examined. Further, differences in drug costs increased over time. This review highlights the importance of performing real-world CE Analysis on cancer treatments to better understand their costs and impacts on a general patient population.

26 September 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
JHJeffrey S Hoch
Jeffrey S Hoch
HBHeather K Barr
Heather K Barr
AGAndrea Michelle Guggenbickler
Andrea Michelle Guggenbickler
CDCarolyn S. Dewa
Carolyn S. Dewa
Background: Smoking among patients diagnosed with cancer poses important health and financial challenges including reduced effectiveness of expensive cancer therapies. This study explores the value of smoking cessation programs (SCPs) for patients already diagnosed with cancer. It also identifies conditions under which SPCs may be wise investments. Methods: Using a simplified decision analytic model combined with insights from a literature review, we explored the cost-effectiveness of SCPs. Results: The findings provide insights about the potential impact of cessation probabilities among cancer patients in SCPs and the potential impact of SCPs on cancer patients’ lives. Conclusion: The evidence suggests that there is good reason to believe that SCPs are an economically attractive way to improve outcomes for cancer patients when SCPs are offered in conjunction with standard cancer care.

7 April 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
HBHeather K Barr
Heather K Barr
AGAndrea Michelle Guggenbickler
Andrea Michelle Guggenbickler
JHJeffrey S Hoch
Jeffrey S Hoch
CDCarolyn S. Dewa
Carolyn S. Dewa
Cost-effectiveness analyses of new cancer treatments in real-world settings (e.g., post-clinical trials) inform healthcare decision makers about their healthcare investments for patient populations. The results of these analyses are often, though not always, presented with statistical uncertainty. This paper identifies five ways to characterize statistical uncertainty: (1) a 95% confidence interval (CI) for the incremental cost-effectiveness ratio (ICER); (2) a 95% CI for the incremental net benefit (INB); (3) an INB by willingness-to-pay (WTP) plot; (4) a cost-effectiveness acceptability curve (CEAC); and (5) a cost-effectiveness scatterplot. It also explores their usage in 22 articles previously identified by a rapid review of real-world cost effectiveness of novel cancer treatments. Seventy-seven percent of these articles presented uncertainty results. The majority those papers (59%) used administrative data to inform their analyses while the remaining were conducted using models. Cost-effectiveness scatterplots were the most commonly used method (34.3%), with 40% indicating high levels of statistical uncertainty, suggesting the possibility of a qualitatively different result from the estimate given. Understanding the necessity for and the meaning of uncertainty in real-world cost-effectiveness analysis will strengthen knowledge translation efforts to improve patient outcomes in an efficient manner.

1 November 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
ZGZahra Goliaei
Zahra Goliaei
ZCZaina Chaban
Zaina Chaban
SASeyedeh Ala Amrei
Seyedeh Ala Amrei
YAYasamin Pashmineh Azar
Yasamin Pashmineh Azar
LALaila Z Afzal
Laila Z Afzal
AGAndrea Michelle Guggenbickler
Andrea Michelle Guggenbickler
Domestic violence (DV) has been reported high in minorities across the US. Among minorities, refugees and immigrants encounter several barriers that may influence their responses and actions regarding DV. This scoping review examined three decades of literature (1980-2022) on resettled Afghan and Arab refugee women's attitudes and behaviors toward DV in their host countries, and to summarize research, practice, and policy recommendations. Based on Arksey and O'Malley model, our scoping review conducted extensive searches in SCOPUS, PubMed, PsychInfo, CINAHL, Web of Science, the Directory of Open Access Journals, and Embase databases. Searches identified articles that examined resettled Afghan and/or Arab refugees’ responses to DV in Western countries. The search identified 439 unique citations; 17 met the inclusion/exclusion criteria. Major themes included acculturative changes in refugee attitudes and behaviors and in stakeholders’ perspectives and roles. Significant acculturative attitudinal changes (acknowledgment, silence, justification, or disapproval of DV) contrasted with minimal behavioral changes (help-seeking behaviors, action plans, or barriers to actions) and with a resistance to change in stakeholders (cultural norms and beliefs, community patriarchal normalization of violence, service providers unfamiliarity with client diversity and refugee cultures) in supporting women decision-making regarding DV. Not a single article made explicit policy recommendations.

27 February 2025 in Social Sciences
Verified
Journal Article
Open access
PDF file
APAhmad Fahim Pirzada
Ahmad Fahim Pirzada
ZCZaina Chaban
Zaina Chaban
AGAndrea Michelle Guggenbickler
Andrea Michelle Guggenbickler
SASeyedeh Ala Mokhtabad Amrei
Seyedeh Ala Mokhtabad Amrei
ASArliette Ariel Sulikhanyan
Arliette Ariel Sulikhanyan
PKPatrick MMarius Koga
Patrick MMarius Koga
The forced migration of tens of thousands of refugee doctors exacerbates a phenomenon referred to as “brain waste”. Based on the Arksey and O’Malley model, this scoping review conducted in SCOPUS, ProQuest, CINAHL, and ERIC via EBSCO examines three decades of peer-reviewed literature (1990–2022) on resettled Afghan and Arab refugee International Medical Graduates (rIMGs) attempting, most often unsuccessfully, relicensing/professional reentry in the USA, Canada, the EU, Australia, and New Zealand. The search identified 760 unique citations, of which only 16 met the inclusion/exclusion criteria. Included publications explored (1) systemic and personal barriers to rIMG professional reentry and (2) existing supporting reentry programs and policy recommendations. The findings point to inconsistencies in evaluating medical education credentials and to racial profiling, inequities, and discrimination in residency interviews. The support provided by some programs was perceived as inadequate, confusing, biased, and gendered. The rIMG personal barriers identified included refugees’ unique limitations and life adversities. The review grasps a collection of isolated support programs with widely varying learning performance, unclear buy-in from residency program directors, and weak policy impacts. This analysis highlights the need for legislated and standardized rIMG reentry support programs to reduce physician shortages, health disparities, and, ultimately, IMG brain waste.